Healthcare legislation company Frier Levitt has analyzed FDA enforcement steps in opposition to “investigation only” peptide suppliers. Their summary: the FDA considers an item’s classification dependant on its intended use, not its disclaimers. When Internet websites incorporate dosage guides, reconstitution instructions, or url to forums di